Hedge Fund - VenBio Select Advisor
Sarepta Therapeutics Inc. (SRPT)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2024 - Q1 (2024-03-31) | $562,431,720 | 6.56% | 4,344,444 | $122.50 |
| 2 | 2023 - Q4 (2023-12-31) | $418,934,735 | 5.78% | 4,344,444 | $95.93 |
| 3 | 2023 - Q3 (2023-09-30) | $487,910,500 | 7.61% | 4,025,000 | $113.03 |
| 4 | 2023 - Q2 (2023-06-30) | $529,985,734 | 7.18% | 4,627,888 | $128.81 |
| 5 | 2023 - Q1 (2023-03-31) | $503,079,500 | 7.45% | 3,650,000 | $129.72 |
| 6 | 2022 - Q4 (2022-12-31) | $411,416,500 | 6.14% | 3,175,000 | $115.88 |
| 7 | 2022 - Q3 (2022-09-30) | $350,965,000 | 6.48% | 3,175,000 | $100.79 |
| 8 | 2022 - Q2 (2022-06-30) | $254,114,000 | 5.02% | 3,390,000 | $73.57 |
| 9 | 2022 - Q1 (2022-03-31) | $244,906,000 | 4.47% | 3,135,000 | $76.58 |
| 10 | 2021 - Q4 (2021-12-31) | $281,406,000 | 4.78% | 3,125,000 | $85.49 |
| 11 | 2021 - Q3 (2021-09-30) | $231,200,000 | 3.63% | 2,500,000 | $77.03 |
| 12 | 2021 - Q2 (2021-06-30) | $186,576,000 | 3.24% | 2,400,000 | $75.81 |
| 13 | 2021 - Q1 (2021-03-31) | $160,240,000 | 2.76% | 2,150,000 | $92.28 |
| 14 | 2020 - Q4 (2020-12-31) | $298,358,000 | 5.13% | 1,750,000 | $148.17 |
| 15 | 2020 - Q3 (2020-09-30) | $235,220,000 | 3.34% | 1,675,000 | $151.97 |
| 16 | 2020 - Q2 (2020-06-30) | $268,570,000 | 5.3% | 1,675,000 | $136.08 |
| 17 | 2020 - Q1 (2020-03-31) | $155,045,000 | 5.23% | 1,585,000 | $114.31 |
| 18 | 2019 - Q4 (2019-12-31) | $227,110,000 | 6.66% | 1,760,000 | $100.93 |
| 19 | 2019 - Q3 (2019-09-30) | $126,387,000 | 5.27% | 1,678,000 | $118.10 |
| 20 | 2019 - Q2 (2019-06-30) | $212,730,000 | 7.35% | 1,400,000 | $121.54 |
| 21 | 2019 - Q1 (2019-03-31) | $142,432,000 | 6.15% | 1,195,000 | $128.56 |
| 22 | 2018 - Q4 (2018-12-31) | $139,141,000 | 8.31% | 1,275,000 | $125.06 |
| 23 | 2018 - Q3 (2018-09-30) | $152,385,000 | 6.99% | 943,500 | $136.70 |
| 24 | 2018 - Q2 (2018-06-30) | $126,751,000 | 4.87% | 958,928 | $94.31 |
| 25 | 2017 - Q1 (2017-03-31) | $0 | 0% | 0 | $30.95 |
| 26 | 2016 - Q4 (2016-12-31) | $27,713,000 | 5.59% | 1,010,300 | $40.16 |
| 27 | 2016 - Q3 (2016-09-30) | $84,126,000 | 14.76% | 1,369,909 | $30.23 |
| 28 | 2016 - Q2 (2016-06-30) | $26,930,000 | 5.98% | 1,412,190 | $18.47 |
| 29 | 2016 - Q1 (2016-03-31) | $22,546,000 | 7.86% | 1,155,000 | $17.47 |
| 30 | 2015 - Q4 (2015-12-31) | $19,406,000 | 6.68% | 503,007 | $32.42 |
| 31 | 2015 - Q3 (2015-09-30) | $15,060,000 | 3.91% | 469,025 | $33.93 |
The displayed share prices are average quarterly stock market prices.
The share numbers are adjusted according to following stock splits:
-
1.0000:6.0000 on 2012-07-12